Figure 2.
Observed changes in CA 15-3 levels in patients with de novo disease progression from baseline to 4th treatment (n = 32).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.